Clinical Trial Update: Preventive VT Substrate Ablation in Ischemic Heart Disease [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update on preventive substrate ablation for ventricular tachycardia in ischemic heart disease (status: unknown).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ischemic Heart Disease
• Myocardial Infarction
• Ventricular Arrhythmia
• Ventricular Tachycardia

Snippet

Sponsor: Centro Medico Teknon | Conditions: Ventricular Tachycardia, Ventricular Arrythmia | Phase 3 | Status: UNKNOWN